Scientists develop new Hepatitis C screening method

Scientists based in Pakistan have used quantitative analysis processes to identify an alternative screening method for hepatitis C infection.

In a study published by the Virology Journal, the team explained that there was a real need for a more sensitive and specific screening process in order to correctly and quickly diagnose infection.

Hepatitis C infection (HCV) is one of several viruses which cause inflammation of the liver and up to five per cent of those infected will die from complications caused by the infection.

According to the report, HCV is becoming a significant threat in Pakistan as instances are increasing at an "alarming rate".

Using quantitative analysis methods, the scientists developed a screening assay with accuracy levels of 100 per cent when used on a standardised panel of 200 HCV positive and 200 HCV negative sera.

Following these results, the team confirmed that they have created a screening process which is more sensitive, specific and reproducible than current commercially available methods in Pakistan.